Paris Colon Cancer Congress 2026

On site event

Paris Colon Cancer Congress 2026

Overview

Event Highlights

  • Uniting colorectal cancer specialists, multidisciplinary care teams, researchers, and patient advocates to advance evidence-based and patient-centered care.
  • Highlighting innovation across early-onset, localized, and metastatic colorectal cancer, including immunotherapy, biomarkers, treatment sequencing, and survivorship.
  • Giving international experts and patients a platform to share perspectives, debate challenging clinical areas, and improve colorectal cancer outcomes worldwide.

Date / Time

Dec 10, 2026 – Dec 12, 2026

The Paris Colon Cancer Congress 2026 (P3C) is an international congress dedicated to advancing the multidisciplinary management of colorectal cancer. It will bring together oncologists, surgeons, researchers, healthcare professionals, patient advocates, and leaders to discuss scientific developments and practical challenges in colorectal cancer care.

The programme will address early-onset, localized, and metastatic colorectal cancer, immunotherapy, biomarker-driven treatment, survivorship, quality of life, and multidisciplinary decision-making.

Organized by the Young Oncologist in GI Group – Europe, part of the OncoDaily ecosystem, P3C will provide a platform for international experts and patients to share experience, debate challenging areas, and discuss ways to improve access, communication, and outcomes.

Scientific Leadership

Julien Taieb – France

Professor of Gastroenterology and Gastrointestinal Oncology, Université Paris Cité
Head, Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, AP-HP
Member, Institut du Cancer Paris CARPEM
Founder, AGEO French Research Group on Gastrointestinal Tumors

Annalice Gandini – France

Medical Oncologist and Researcher, Centre de Recherche des Cordeliers, Paris
Researcher, Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou
PhD Researcher in Integrative and Translational Biology, Université Paris Cité
Researcher, SIRIC CARPEM Comprehensive Cancer Center

Amalya Sargsyan – Armenia

Amalya Sargsyan, MD, MSc
Medical Oncologist, Adult Solid Tumors and Chemotherapy Clinic, Yeolyan Hematology and Oncology Center
Head, Sarcoma Service, D’Clinic
Vice President, Research & Intelligence, OncoDaily
Adjunct Assistant Professor, Yerevan State Medical University
Research Physician, Immune Oncology Research Institute (IMMONC)
Founder, Young Oncology Group of Armenia

Francisco Javier Ros – Spain

Medical Oncologist, Department of Medical Oncology, Vall d’Hebron University Hospital
Clinical Investigator, Vall d’Hebron Institute of Oncology (VHIO)
Member, Gastrointestinal Tract Tumours Group, VHIO
Colon Cancer Team, VHIO

News & Updates

No updates yet.